Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Operating Leases (2022 - 2026)

Rallybio's Operating Leases history spans 4 years, with the latest figure at $176000.0 for Q4 2025.

  • On a quarterly basis, Operating Leases changed N/A to $176000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $176000.0, a N/A change, with the full-year FY2025 number at $176000.0, changed N/A from a year prior.
  • Operating Leases hit $176000.0 in Q4 2025 for Rallybio, up from $108000.0 in the prior quarter.
  • Over the last five years, Operating Leases for RLYB hit a ceiling of $555000.0 in Q4 2022 and a floor of $58000.0 in Q2 2024.
  • Historically, Operating Leases has averaged $220444.4 across 4 years, with a median of $176000.0 in 2025.
  • The widest YoY moves for Operating Leases: up 63.86% in 2024, down 78.2% in 2024.
  • Tracing RLYB's Operating Leases over 4 years: stood at $555000.0 in 2022, then tumbled by 68.83% to $173000.0 in 2023, then tumbled by 66.47% to $58000.0 in 2024, then skyrocketed by 203.45% to $176000.0 in 2025.
  • Business Quant data shows Operating Leases for RLYB at $176000.0 in Q4 2025, $108000.0 in Q3 2025, and $58000.0 in Q2 2024.